Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    1.99
    -0.01 (-0.50%)
    At close: Jun 17, 2025, 12:30 PM

    Inovio Pharmaceuticals Statistics

    Share Statistics

    Inovio Pharmaceuticals has 36.67M shares outstanding. The number of shares has increased by 41.51% in one year.

    Shares Outstanding

    n/a
    		 36.67M

    Shares Change (YoY)

    n/a
    		 41.51%

    Shares Change (QoQ)

    n/a
    		 1.57%

    Owned by Institutions (%)

    n/a
    		 47.43%

    Shares Floating

    n/a
    		 36.39M

    Failed to Deliver (FTD) Shares

    n/a
    		 34,256

    FTD / Avg. Volume

    n/a
    		 5.08%

    Short Selling Information

    The latest short interest is 6.57M, so 17.91% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.57M

    Short % of Shares Out

    n/a
    		 17.91%

    Short % of Float

    n/a
    		 18.03%

    Short Ratio (days to cover)

    n/a
    		 10.87

    Valuation Ratios

    The PE ratio is -0.46 and the forward PE ratio is -1.12. Inovio Pharmaceuticals's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.46

    Forward PE

    n/a
    		 -1.12

    PS Ratio

    n/a
    		 228.26

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -0.48

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Inovio Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.17.

    Current Ratio

    n/a
    		 2.77

    Quick Ratio

    n/a
    		 2.77

    Debt / Equity

    n/a
    		 0.17

    Debt / EBITDA

    n/a
    		 -114.15

    Debt / FCF

    n/a
    		 -113.47

    Interest Coverage

    n/a
    		 -632.05

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,625.04

    Profits Per Employee

    n/a
    		 $-800,403.93

    Employee Count

    n/a
    		 134

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -107.15B

    Effective Tax Rate

    n/a
    		 99.9%

    Stock Price Statistics

    The stock price has increased by -77.63% in the last 52 weeks. The beta is 1.31, so Inovio Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.31

    52-Week Price Change

    n/a
    		 -77.63%

    50-Day Moving Average

    n/a
    		 1.91

    200-Day Moving Average

    n/a
    		 3.26

    Relative Strength Index (RSI)

    n/a
    		 47.44

    Average Volume (20 Days)

    n/a
    		 673,682

    Income Statement

    In the last 12 months, Inovio Pharmaceuticals had revenue of 217.76K and earned -107.25M in profits. Earnings per share was -3.95.

    Revenue

    n/a
    		 217.76K

    Gross Profit

    n/a
    		 -2.91M

    Operating Income

    n/a
    		 -112.4M

    Net Income

    n/a
    		 -107.25M

    EBITDA

    n/a
    		 -103.95M

    EBIT

    n/a
    		 -107.08M

    Earnings Per Share (EPS)

    n/a
    		 -3.95
    Full Income Statement

    Balance Sheet

    The company has 65.81B in cash and 11.87B in debt, giving a net cash position of 53.95B.

    Cash & Cash Equivalents

    n/a
    		 65.81B

    Total Debt

    n/a
    		 11.87B

    Net Cash

    n/a
    		 53.95B

    Retained Earnings

    n/a
    		 -1,730.2B

    Total Assets

    n/a
    		 87.27B

    Working Capital

    n/a
    		 44.57B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -104.08M and capital expenditures -487.83K, giving a free cash flow of -104.56M.

    Operating Cash Flow

    n/a
    		 -104.08M

    Capital Expenditures

    n/a
    		 -487.83K

    Free Cash Flow

    n/a
    		 -104.56M

    FCF Per Share

    n/a
    		 -3.85
    Full Cash Flow Statement

    Margins

    Gross margin is -1337.41%, with operating and profit margins of -51616.91% and -49254.27%.

    Gross Margin

    n/a
    		 -1337.41%

    Operating Margin

    n/a
    		 -51616.91%

    Pretax Margin

    n/a
    		 -49254269%

    Profit Margin

    n/a
    		 -49254.27%

    EBITDA Margin

    n/a
    		 -47735.19%

    EBIT Margin

    n/a
    		 -51616.91%

    FCF Margin

    n/a
    		 -48019.06%

    Dividends & Yields

    INO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for INO is $13, which is 550% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $13

    Price Target Difference

    n/a
    		 550%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 25, 2024. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Jan 25, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -28.41

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist